<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Orbital</provider_name><provider_url>https://www.orbital-itn.eu</provider_url><author_name>hammad</author_name><author_url>https://www.orbital-itn.eu/author/hammad/</author_url><title>Project 3: Intrascleral Implants for Posterior Segment Drug Delivery - Orbital</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content"&gt;&lt;a href="https://www.orbital-itn.eu/projects/project-3-intrascleral-implants-for-posterior-segment-drug-delivery/"&gt;Project 3: Intrascleral Implants for Posterior Segment Drug Delivery&lt;/a&gt;&lt;/blockquote&gt;
&lt;script type='text/javascript'&gt;
&lt;!--//--&gt;&lt;![CDATA[//&gt;&lt;!--
		/*! This file is auto-generated */
		!function(d,l){"use strict";var e=!1,o=!1;if(l.querySelector)if(d.addEventListener)e=!0;if(d.wp=d.wp||{},!d.wp.receiveEmbedMessage)if(d.wp.receiveEmbedMessage=function(e){var t=e.data;if(t)if(t.secret||t.message||t.value)if(!/[^a-zA-Z0-9]/.test(t.secret)){var r,a,i,s,n,o=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),c=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]');for(r=0;r&lt;c.length;r++)c[r].style.display="none";for(r=0;r&lt;o.length;r++)if(a=o[r],e.source===a.contentWindow){if(a.removeAttribute("style"),"height"===t.message){if(1e3&lt;(i=parseInt(t.value,10)))i=1e3;else if(~~i&lt;200)i=200;a.height=i}if("link"===t.message)if(s=l.createElement("a"),n=l.createElement("a"),s.href=a.getAttribute("src"),n.href=t.value,n.host===s.host)if(l.activeElement===a)d.top.location.href=t.value}}},e)d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",t,!1),d.addEventListener("load",t,!1);function t(){if(!o){o=!0;var e,t,r,a,i=-1!==navigator.appVersion.indexOf("MSIE 10"),s=!!navigator.userAgent.match(/Trident.*rv:11\./),n=l.querySelectorAll("iframe.wp-embedded-content");for(t=0;t&lt;n.length;t++){if(!(r=n[t]).getAttribute("data-secret"))a=Math.random().toString(36).substr(2,10),r.src+="#?secret="+a,r.setAttribute("data-secret",a);if(i||s)(e=r.cloneNode(!0)).removeAttribute("security"),r.parentNode.replaceChild(e,r)}}}}(window,document);
//--&gt;&lt;!]]&gt;
&lt;/script&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://www.orbital-itn.eu/projects/project-3-intrascleral-implants-for-posterior-segment-drug-delivery/embed/" width="600" height="338" title="&#x201C;Project 3: Intrascleral Implants for Posterior Segment Drug Delivery&#x201D; &#x2014; Orbital" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;</html><thumbnail_url>https://www.orbital-itn.eu/app/uploads/2020/03/orbital-partner-icon-2@2x.png</thumbnail_url><thumbnail_width>530</thumbnail_width><thumbnail_height>226</thumbnail_height><description>Chronic retinal diseases are the leading contributor to visual impairment and blindness that are potentially the most devastating health problem worldwide. The World Health Organization estimates that globally about 285M people are visually impaired, of which 39M are blind and 246M have low vision. Diseases that originate in the posterior segment (PS) or back of &hellip; Read More</description></oembed>
